← Back to Clinical Trials
Recruiting NCT06860113

NCT06860113 Evaluation of Retrograde Intra Renal Surgery in the T-tilted Position

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06860113
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Stone, Kidney
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2025-03-01
Primary Completion 2025-10-30

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
T-tilting of the patient during surgerystandard lithotomy position

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2025-03-01 with a primary completion date of 2025-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To evaluate the effect of the T-tilted position on the stone-free rate compared to the standard lithotomy position in retrograde intrarenal surgeries. Common positions include the Trendelenburg position, where the patient is tilted head-down to help gravity move stones from the upper calyces to the renal pelvis, and the modified lateral decubitus position, which improves access to the lower renal poles. A more recent approach, the modified T-tilt position, combines a slight Trendelenburg tilt with lateral positioning, offering optimal access to both the upper and lower calyces while maintaining patient comfort

Eligibility Criteria

Inclusion Criteria: * All patients above the age of 16 years of either sex who did not have a pre-existing ureteral stent presented to the Urology clinic in our university hospitals with kidney stones with size up to 2.5cm (estimated by CTUT as the greatest dimension or the summation of the greatest dimensions). Exclusion Criteria: * Previous open renal surgery or renal trauma. * Patients with renal anomalies. * Patients with untreated or active UTI. * Patients who suffer from medical conditions that preclude the application of Trendelenburg position (lung disease, congestive heart failure).

Contact & Investigator

Central Contact

Emad Tawfeik, MBBCH

✉ emadmamdouh676@gmail.com

📞 +2001210235447

Frequently Asked Questions

Who can join the NCT06860113 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying Stone, Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06860113 currently recruiting?

Yes, NCT06860113 is actively recruiting participants. Contact the research team at emadmamdouh676@gmail.com for enrollment information.

Where is the NCT06860113 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06860113 clinical trial?

NCT06860113 is sponsored by Ain Shams University. The trial plans to enroll 160 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology